PSMA ligands and uses thereof
US10363313B2 · kind B2 · utility
10Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2018 |
| Grant date | Jul 30, 2019 |
| Priority date | — |
| Expiry date | Feb 13, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds that are PSMA ligands, pharmaceutical compositions comprising these compounds, methods for treating and detecting cancers in a subject, methods for identifying cancer cells in a sample are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.